Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma — HNJ-NKAES-2012  

Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma Clinical Trial

Official title: Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma.

Status Terminated

Clinical Trial Summary

To determine safety profile of immunotherapy with natural killer cells and activated expanded (NKAEs) after salvage chemotherapy in relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Leukemia
• Leukemia, Lymphoid
• Lymphoma
• Precursor Cell Lymphoblastic Leukemia-Lymphoma
• Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

• NCT number: NCT01944982
• Study type: Interventional
• Source: Hospital Infantil Universitario Niño Jesús, Madrid, Spain
• Status: Terminated
• Phase: Phase 1/Phase 2
• Start date: July 2013
• Completion date: September 2016